Radiology Case Reports (Apr 2021)

A case report of mesenchymal scapular FGF secreting tumor: Importance of follow up in tumor induced osteomalacia

  • Trilok Shrivastava, MD,
  • Jessica L Hwang, MD,
  • Laishiya Munshi, DO,
  • Kumar Kunnal Batra, MD,
  • Kriti Ahuja, MD

Journal volume & issue
Vol. 16, no. 4
pp. 989 – 993

Abstract

Read online

A 46-year-old Asian male with history of atraumatic fracture of femur (requiring the use of a walker), muscle cramps and loosening teeth presents to Endocrine clinic. He had elevated parathyroid hormone, severely low phosphorus, elevated bone-specific ALP, with normal serum and urine calcium. He was found to have elevated FGF 23 levels, but initial functional and anatomic imaging was negative for any localizing tumor. With persistent follow-up and serial imaging, after 3 years, a 2.2 cm right scapular mass was found on MRI. Since it was also visualized on PET/CT, this was suspected to be the cause of his severe hypophosphatemia. He underwent surgical excision and pathology revealed a phosphaturic mesenchymal tumor after excision. Tumor induced osteomalacia is a rare, acquired paraneoplastic syndrome in which a tumor that secretes FGF23 leads to decreased renal phosphate reabsorption, resulting in hypophosphatemia, and bone demineralization. Diagnosis is challenging as common presenting symptoms are nonspecific, but when followed up closely with proper diagnostic modalities, identification & removal of the culprit lesion is usually curative.

Keywords